APA (7th ed.) Citation

Al-Ibraheem, A., Moghrabi, S., Alsyouf, B., Abdulrahman, M., Al-Foqaha, M., Al-Tameemi, F., . . . Mansour, A. (2026). Is There an Added Value of Dual-Time-Point [ 68 Ga]Ga–Fibroblast Activation Protein Inhibitor (FAPI) PET/CT in Differentiating Malignant and Benign Uptake Findings? Cancers, 18(12), 1963. https://doi.org/10.3390/cancers18121963

Chicago Style (17th ed.) Citation

Al-Ibraheem, Akram, et al. "Is There an Added Value of Dual-Time-Point [ 68 Ga]Ga–Fibroblast Activation Protein Inhibitor (FAPI) PET/CT in Differentiating Malignant and Benign Uptake Findings?" Cancers 18, no. 12 (2026): 1963. https://doi.org/10.3390/cancers18121963.

MLA (9th ed.) Citation

Al-Ibraheem, Akram, et al. "Is There an Added Value of Dual-Time-Point [ 68 Ga]Ga–Fibroblast Activation Protein Inhibitor (FAPI) PET/CT in Differentiating Malignant and Benign Uptake Findings?" Cancers, vol. 18, no. 12, 2026, p. 1963, https://doi.org/10.3390/cancers18121963.